ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 13 filers reported holding ZEALAND PHARMA A S in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,417,000 | -30.0% | 85,799 | -46.2% | 0.00% | -33.3% |
| Q2 2018 | $2,023,000 | -21.2% | 159,573 | -6.6% | 0.00% | 0.0% |
| Q1 2018 | $2,566,000 | +494.0% | 170,844 | +438.1% | 0.00% | +200.0% |
| Q4 2017 | $432,000 | -67.8% | 31,752 | -54.6% | 0.00% | -50.0% |
| Q3 2017 | $1,343,000 | – | 69,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 750,000 | $25,875,000 | 0.22% |
| AWM Investment Company, Inc. | 19,981 | $689,000 | 0.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $183,000 | 0.08% |
| OLD MISSION CAPITAL LLC | 15,890 | $548,000 | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,433,091 | $49,442,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $345,000 | 0.01% |
| STATE OF WISCONSIN INVESTMENT BOARD | 44,092 | $1,521,000 | 0.01% |
| Rockefeller Capital Management L.P. | 8,876 | $306,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 236 | $10,000 | 0.00% |
| Filbrandt Wealth Management, LLC | 25 | $1,000 | 0.00% |